OptiNose, Inc.
OPTN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.63 | -0.00 | 0.58 |
| FCF Yield | -65.96% | -0.96% | -42.61% | -5.58% |
| EV / EBITDA | -93.76 | -143.18 | -3.41 | -21.34 |
| Quality | ||||
| ROIC | -17.42% | -36.49% | -58.20% | -60.52% |
| Gross Margin | 90.76% | 87.84% | 87.86% | 87.74% |
| Cash Conversion Ratio | 2.08 | 0.58 | 0.90 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.85% | -1.66% | 15.80% | 29.18% |
| Free Cash Flow Growth | -114.53% | 69.19% | 12.18% | 11.12% |
| Safety | ||||
| Net Debt / EBITDA | -37.13 | -3.73 | -0.64 | -0.31 |
| Interest Coverage | -0.81 | -1.16 | -3.32 | -4.16 |
| Efficiency | ||||
| Inventory Turnover | 0.63 | 1.07 | 0.98 | 0.77 |
| Cash Conversion Cycle | 679.05 | 278.59 | 325.98 | 326.25 |